Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05384223 · ClinicalTrials.gov registry record · NA

Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens

A NA study of PTSD and Substance Use Disorders, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
212
Enrollment target
2
Study locations

NCT05384223: Active NA study of PTSD and Substance Use Disorders, sponsored by Medical University of South Carolina.

NCT05384223 is a NA study of PTSD and Substance Use Disorders that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 212 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05384223, a NA study of PTSD and Substance Use Disorders, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
212 participants
Enrollment target
2
Study locations

Study Summary

Psychosocial traumatic events during childhood, serve as strong and consistent predictors of substance use problems (SUP) during adolescence and adulthood.PTSD that extends from such trauma often co-occurs with SUP. Despite this well-established link, standard care for adolescents with co-occurring SUP and PTSD for the last several decades has been to treat these problems separately. This compartmentalized approach to treatment creates a burden on teens and families, raises unique challenges to clinicians in both mental health and addiction domains, and may contribute to high rates of SUP relapse among adolescents with co-occurring PTSD. To address this problem, our team recently completed a rigorous National Institute on Drug Abuse (NIDA)-funded randomized controlled trial (RCT) supporting the efficacy of an integrative, exposure-based treatment we developed, Risk Reduction through Family Therapy (RRFT), in greater long term reductions in SUP, as well as PTSD avoidance and hyperarousal symptoms, in comparison to standard treatment in a large teen sample. The proposed RCT, with an effectiveness-implementation Hybrid Type I design, substantially builds on that prior research by proposing to 1) evaluate whether RRFT's clinical effectiveness for reducing SUP and PTSD can be extended to youth in outpatient substance use treatment settings-where youth are presenting for SUP treatment and where clinicians often have less experience treating PTSD (Aim 1); 2)evaluate the cost-effectiveness of RRFT and to explore inner context variables (e.g., perceived treatment acceptability, attitudes, and satisfaction among the participating adolescents, caregivers, agency leaders, and therapists and barriers to and facilitators of implementation) that might affect RRFT implementation in diverse practice settings(Aim 2). The proposed effectiveness-implementation trial will recruit adolescents (13-18 years) with a history of psychosocial trauma presenting with SUP and PTSD symptoms for ou

Primary Outcome

The Timeline Follow Back (TLFB) is a validated, subjective measure that uses a calendar for people to provide estimates of substance use (drugs/alcohol) on a daily basis, retrospectively. Key dates and calendars are used to aid in memory recall. The measure is beneficial in both clinical and research environments. Over time, the TLFB looks for a decrease in substance use. Higher numbers of substance use are indicative of greater substance use.

Interventions

  • BEHAVIORAL RRFT (Risk Reduction through Family Therapy)
  • BEHAVIORAL ENCOMPASS (Integrated Treatment for Adolescents and Young Adults)

Study Locations (2)

Colorado

  • CU Medicine Psychiatry - Outpatient Clinic - Aurora
  • ARTS - Synergy Outpatient Services - Denver

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2022-10-15
Est. Completion 2027-02-28
Phase NA

What the registry record for NCT05384223 still lists

NCT05384223 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (30% lower).

The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which RRFT (Risk Reduction through Family Therapy) is the first listed.

NCT05384223 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT05384223 about?

NCT05384223 is a clinical study titled "Evaluation of RRFT for Co-occurring SUD and PTSD Among Teens". Psychosocial traumatic events during childhood, serve as strong and consistent predictors of substance use problems (SUP) during adolescence and adulthood.PTSD that extends from such trauma often co-occurs with SUP. Despite this well-established link, standard care for adolescents with co-occurring ...

What is the current status of trial NCT05384223?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 212 participants. The study started on 2022-10-15. Estimated completion is 2027-02-28.

What conditions does trial NCT05384223 study?

This clinical trial studies the following conditions: PTSD, Substance Use Disorders.

What interventions are being tested in trial NCT05384223?

The interventions under investigation include: RRFT (Risk Reduction through Family Therapy) (BEHAVIORAL), ENCOMPASS (Integrated Treatment for Adolescents and Young Adults) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05384223?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05384223 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05384223's enrollment target sits among peer trials

212 24th of 154 higher than 131 of 154 other PTSD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04228978 · 212 participants · NA

    Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss

  • NCT04725721 · 212 participants · NA

    Testing FIRST in Youth Outpatient Psychotherapy

  • NCT06257576 · 212 participants · Phase 3

    Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter

  • NCT06456593 · 212 participants · Phase 2

    Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05384223, the US trial registry maintained by the National Library of Medicine. NCT05384223 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.